Evidence map›Paper›PMID 38545709›Full record

ArticleLa Tunisie medicale2024

Nabila Kalla, Hamouda Ouanassa, Lina Noui, Amani Melizi, Souhila Aouidane, Zohra Merzougui

Open access · diamondAbstract readEnglish Abstract
In one paragraph

Article in La Tunisie medicale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nabila KallaFaculty of Medicine of Batna, University of Batna, Algeria.
Hamouda OuanassaFaculty of Medicine of Batna, University of Batna, Algeria.
Lina NouiFaculty of Medicine of Batna, University of Batna, Algeria.
Amani MeliziFaculty of Medicine of Batna, University of Batna, Algeria.
Souhila AouidaneFaculty of Medicine of Batna, University of Batna, Algeria.
Zohra MerzouguiFaculty of Medicine of Batna, University of Batna, Algeria.
University of Batna 1 · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn recent years, there has been a considerable increase in the prevalence of bacteria increasingly resistant to multiple families of antibiotics, which constitutes a major problem for public health.

aimTo determine the prevalence and different risk factors for the acquisition of multi-resistant bacteria.

methodsThis is an analytical and prospective study including patients hospitalized in the Batna University Hospital during the period from January 2023 to March 2023 presenting a documented infection with isolation of sensitive or multi-resistant strains. An operating sheet based on the different risk factors for acquiring multi-resistant bacteria has been established.

resultsWe collected 250 patients. There are 160 men and 90 women with an average age of 44 years. Of all the strains that were identified, 100 isolates were multi-resistant bacteria. ESBL-producing Enterobacteriaceae are the most frequently isolated multi-resistant bacteria. Multivariate logistic regression analysis identified four risk factors that are significantly related to the risk of acquiring multi-resistant bacteria infection: prior antibiotic therapy [P = 0,029], use of invasive medical care [P = 0,024], the nosocomial origin of the infection [P = 0,036] and the use of public toilets [P = 0,015].

conclusionOur results clearly demonstrate that the inappropriate use of antibiotics, especially broad-spectrum antibiotics, and hand-held cross-transmission play a major role in the spread of multi-resistant bacteria in our hospital.

Indexed as

Cross InfectionEnterobacteriaceae InfectionsAdultAnti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialFemaleHospitals, UniversityHumansMaleMicrobial Sensitivity TestsProspective StudiesRisk FactorsAnti-Bacterial Agentsbeta-LactamasesAcquisitionmulti-resistant bacteriaPrevalenceRisk factors

Identifiers

PMID38545709
PMCPMC11358779
OpenAlexW4392629161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.